Economic Impact of a triptan Rx-To-OTC Switch in Six EU Countries

Por Millier, Aurelie, Cohen, Joshua, Toumi, Mondher
Publicado em 2013

Drug repurposing in pharmaceutical industry and its impact on market access: market access implications

Por Murteira, Susana, Millier, Aurélie, Toumi, Mondher
Publicado no J Mark Access Health Policy (2014)

Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications

Por Murteira, Susana, Millier, Aurélie, Ghezaiel, Zied, Lamure, Michel
Publicado no J Mark Access Health Policy (2014)

Attitudes and beliefs of the French public about schizophrenia and major depression: results from a vignette-based population survey

Por Angermeyer, Matthias C, Millier, Aurélie, Rémuzat, Cécile, Refaï, Tarek, Toumi, Mondher
Publicado em 2013

Predictive models to estimate utility from clinical questionnaires in schizophrenia: findings from EuroSC

Por Siani, Carole, de Peretti, Christian, Millier, Aurélie, Boyer, Laurent, Toumi, Mondher
Publicado no Qual Life Res (2015)

Quality of life is predictive of relapse in schizophrenia

Por Boyer, Laurent, Millier, Aurelie, Perthame, Emeline, Aballea, Samuel, Auquier, Pascal, Toumi, Mondher
Publicado em 2013

A critical literature review of health economic evaluations of rotavirus vaccination

Por Aballéa, Samuel, Millier, Aurélie, Quilici, Sibilia, Caroll, Stuart, Petrou, Stavros, Toumi, Mondher
Publicado em 2013

Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populations

Por Thokagevistk, Katia, Millier, Aurélie, Lenert, Leslie, Sadikhov, Shamil, Moreno, Santiago, Toumi, Mondher
Publicado no J Mark Access Health Policy (2016)

Determinants of orphan drugs prices in France: a regression analysis

Por Korchagina, Daria, Millier, Aurelie, Vataire, Anne-Lise, Aballea, Samuel, Falissard, Bruno, Toumi, Mondher
Publicado no Orphanet J Rare Dis (2017)

Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis

Por Millier, Aurelie, Sarlon, Emmanuelle, Azorin, Jean-Michel, Boyer, Laurent, Aballea, Samuel, Auquier, Pascal, Toumi, Mondher
Publicado em 2011

Current process and future path for health economic assessment of pharmaceuticals in France

Por Toumi, Mondher, Rémuzat, Cécile, El Hammi, Emna, Millier, Aurélie, Aballéa, Samuel, Chouaid, Christos, Falissard, Bruno
Publicado no J Mark Access Health Policy (2015)

Modelling the consequences of a reduction in alcohol consumption among patients with alcohol dependence based on real-life observational data

Por Rahhali, Nora, Millier, Aurélie, Briquet, Benjamin, Laramée, Philippe, Aballéa, Samuel, Toumi, Mondher, François, Clément, Rehm, Jürgen, Daeppen, Jean-Bernard
Publicado no BMC Public Health (2015)

A prospective study of health care resource utilisation and selected costs of schizophrenia in France

Por Sarlon, Emmanuelle, Heider, Dirk, Millier, Aurélie, Azorin, Jean-Michel, König, Hans-Helmut, Hansen, Karina, Angermeyer, Matthias C, Aballéa, Samuel, Toumi, Mondher
Publicado em 2012